Performed a comprehensive strategic and financial valuation of GSK Consumer Healthcare for HUL’s acquisition decision—assessing strategic fit.
Modelling DCF and relative valuations (standalone vs. synergy-adjusted), benchmarking peers, and evaluating integration synergies and long-term value creation to determine deal justification.
